HCM
Hutchinson Capital Management Portfolio holdings
AUM
$548M
1-Year Return
12.58%
This Quarter Return
+14.07%
1 Year Return
+12.58%
3 Year Return
+50.43%
5 Year Return
+107.91%
10 Year Return
+193.52%
AUM
$351M
AUM Growth
+$42.2M
(+14%)
Cap. Flow
+$2.94M
Cap. Flow
% of AUM
0.84%
Top 10 Holdings %
Top 10 Hldgs %
54.7%
Holding
63
New
4
Increased
26
Reduced
18
Closed
4
Top Buys
| 1 |
Intel
INTC
|
$9.31M |
| 2 |
Jefferies Financial Group
JEF
|
$8.5M |
| 3 |
RTX Corp
RTX
|
$723K |
| 4 |
Exxon Mobil
XOM
|
$265K |
| 5 |
Procter & Gamble
PG
|
$260K |
Top Sells
| 1 |
Omnicom Group
OMC
|
$16.5M |
| 2 |
HUB.B
HUBBELL INC CL-B
HUB.B
|
$361K |
| 3 |
Schlumberger
SLB
|
$348K |
| 4 |
Rockwell Automation
ROK
|
$229K |
| 5 |
General Motors
GM
|
$222K |
Sector Composition
| 1 | Financials | 24.58% |
| 2 | Consumer Discretionary | 18.57% |
| 3 | Industrials | 16.91% |
| 4 | Healthcare | 11.99% |
| 5 | Technology | 11.13% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
26
Chevron
CVX
$318B
| $3.33M | 0.95% |
26,677
+100
| +0.4% | +$12.5K |
|
27
Boeing
BA
$174B
| $3.13M | 0.89% |
22,895
-1,325
| -5% | -$181K |
|
28
Pfizer
PFE
$140B
| $2.22M | 0.63% |
76,350
+1,556
| +2% | +$45.2K |
|
|
29
Procter & Gamble
PG
$373B
| $1.97M | 0.56% |
24,153
+3,200
| +15% | +$260K |
|
|
COL
30
DELISTED
Rockwell Collins
COL
| $1.72M | 0.49% |
23,277
-750
| -3% | -$55.5K |
|
|
31
RTX Corp
RTX
$212B
| $1.48M | 0.42% |
20,654
+10,089
| +95% | +$723K |
|
32
Johnson & Johnson
JNJ
$431B
| $1.26M | 0.36% |
13,764
-125
| -0.9% | -$11.5K |
|
|
CST
33
DELISTED
CST Brands, Inc.
CST
| $1.23M | 0.35% |
33,551
+415
| +1% | +$15.2K |
|
34
PepsiCo
PEP
$201B
| $1.14M | 0.32% |
13,715
-50
| -0.4% | -$4.15K |
|
35
GE Aerospace
GE
$299B
| $1.03M | 0.29% |
7,694
+516
| +7% | +$69.3K |
|
36
IBM
IBM
$230B
| $897K | 0.26% |
4,999
+420
| +9% | +$75.4K |
|
37
Target
TGT
$42.1B
| $873K | 0.25% |
13,802
+4,113
| +42% | +$260K |
|
38
Clorox
CLX
$15.2B
| $802K | 0.23% |
8,646
-825
| -9% | -$76.5K |
|
|
RDS.A
39
DELISTED
Royal Dutch Shell PLC ADS Class A
RDS.A
| $770K | 0.22% |
10,810
+1,020
| +10% | +$72.7K |
|
40
Sempra
SRE
$53.6B
| $681K | 0.19% |
15,160
+4,600
| +44% | +$207K |
|
41
Genuine Parts
GPC
$19.6B
| $542K | 0.15% |
6,510
| – | – |
|
42
Bristol-Myers Squibb
BMY
$95B
| $493K | 0.14% |
9,277
-1,950
| -17% | -$104K |
|
43
Abbott
ABT
$231B
| $483K | 0.14% |
12,609
| – | – |
|
44
Novartis
NVS
$249B
| $463K | 0.13% |
6,427
| – | – |
|
45
3M
MMM
$82.8B
| $451K | 0.13% |
3,845
-30
| -0.8% | -$3.52K |
|
46
Coca-Cola
KO
$294B
| $418K | 0.12% |
10,118
-40
| -0.4% | -$1.65K |
|
47
Berkshire Hathaway Class B
BRK.B
$1.09T
| $376K | 0.11% |
3,168
| – | – |
|
48
AbbVie
ABBV
$376B
| $325K | 0.09% |
6,155
-134
| -2% | -$7.08K |
|
49
Marsh & McLennan
MMC
$101B
| $300K | 0.09% |
6,200
-2,950
| -32% | -$143K |
|
|
MON
50
DELISTED
Monsanto Co
MON
| $294K | 0.08% |
2,523
| – | – |
|